Marker Therapeutics stockholders approve issuance of 8.28M warrant shares

Marker Therapeutics, Inc.

At special meeting on March 21, 2025, 4,158,543 shares (38.83% of outstanding) represented.
Proposal passed: 3,483,897 for, 668,383 against, 6,263 abstained.
Approves issuance of up to 5,031,250 shares under Series A Warrants and 3,247,445 under Series B Warrants.
Total authorized warrant shares: 8,278,695, approximately 77% of 10.7M outstanding shares.

item 5.07 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001104659-25-028821
form_type: 8-K
ticker: MRKR
cik: 0001094038
company_name: Marker Therapeutics, Inc.
filed_at: 2025-03-27T23:59:59+00:00
discovered_at: 2026-05-14T18:03:02.912973+00:00
generated_at: 2026-05-24T03:38:18.876899+00:00
sec_items: ["5.07", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.85
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001104659-25-028821
json_url: https://secwatch.observer/filing/0001104659-25-028821.json
markdown_url: https://secwatch.observer/filing/0001104659-25-028821.md
text_url: https://secwatch.observer/filing/0001104659-25-028821.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1094038/000110465925028821/0001104659-25-028821-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1094038/000110465925028821/tm2510592d1_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001104659-25-028821

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.